Static Chart IceCure Medical Ltd

Equities

Delayed Nasdaq Other stock markets 16:00:00 2024-06-18 EDT			5-day change	1st Jan Change
0.789 ^USD	+2.48%		+2.47%	-26.26%

06-04	FDA to Convene Advisory Panel for Review of IceCure Medical Ltd.'s De Novo Marketing Clearance Request for ProSense®, Decision Expected Early 2025	CI
05-28	Transcript : IceCure Medical Ltd, Q1 2024 Earnings Call, May 28, 2024

Duration

Period